Nanoparticle‐Based MRI‐Guided Tumor Microenvironment Heating via the Synergistic Effect of Ferroptosis and Inhibition of TGF‐ β Signaling
Advanced Healthcare Materials · 2023-08 · 12 (21)
DOI: 10.1002/adhm.202300176 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 04.05.2023. Verfasst von Rui Zhou und 6 weiteren Autor:innen. Beteiligte Einrichtung: Nanfang Hospital, Southern Medical University, Department of Oncology, Guangzhou, Guangdong, 510515, P. R. China. Hauptthemen laut MEDLINE: Ferroptosis, Neoplasms, Nanoparticles. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Although induction of ferroptosis and inhibition of transforming growth factor‐ β (TGF‐ β ) signaling are both effective ways to reform the tumor microenvironment (TME) and render low‐immunogenic tumors responsive to immune checkpoint inhibitor therapy, dose‐limiting side effects remain major obstacles hindering their clinical application. Herein, novel sorafenib and anti‐TGF‐ β antibody loaded Fe 3 O 4 /Gd 2 O 3 hybrid nanoparticles with conjugation of arginine‐glycine‐aspartic dimer (FeGd‐HN@Sorafenib@TGF‐ β ‐antibody@RGD2, FG‐STR) are developed. Sorafenib significantly enhances FeGd‐HN‐triggered ferroptosis and improves maturation and phagocytosis of dendritic cells (DCs) by inducing damage‐associated molecular patterns released from ferroptotic cancer cells, while the anti‐TGF‐ β antibody further synergizes with enhanced ferroptosis to promote DC maturation and the recruitment of CD8 + T cells, thus heating the TME. Moreover, the incorporation of RGD2 facilitates the uptake of the FG‐STR in tumor cells which lead to a significant dosage reduction of both sorafenib and anti‐TGF‐ β antibody to avoid dose‐limiting toxicities. Finally, in vitro and in vivo experiments show that FG‐STR has significantly superior intrinsic magnetic resonance imaging (MRI) capability than that of Gadovist, effectively inhibits tumor growth and lung metastasis, and increases the efficacy of anti‐programmed cell death‐1 treatment. Taken together, this study provides a promising strategy for new advanced MRI‐guided TME heating therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nanfang Hospital, Southern Medical University, Department of Oncology, Guangzhou, Guangdong, 510515, P. R. China.
- School of Biomedical Engineering, Southern Medical University, Guangzhou, Guangdong, 510515, P. R. China.
ORCID-Profile: Xiaoxiang Rong
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhou, R., Liu, Y., Wang, Z., Lv, J., Liao, W., Shen, Z., & Rong, X. (2023). Nanoparticle‐Based MRI‐Guided Tumor Microenvironment Heating via the Synergistic Effect of Ferroptosis and Inhibition of TGF‐ β Signaling. Advanced Healthcare Materials, 12(21). https://doi.org/10.1002/adhm.202300176
Vancouver
Zhou R, Liu Y, Wang Z, Lv J, Liao W, Shen Z, et al. Nanoparticle‐Based MRI‐Guided Tumor Microenvironment Heating via the Synergistic Effect of Ferroptosis and Inhibition of TGF‐ β Signaling. Advanced Healthcare Materials. 2023;12(21). doi:10.1002/adhm.202300176
BibTeX
@article{Zhou2023,
author = {Zhou, Rui and Liu, Yantan and Wang, Zhaojun and Lv, Jinyu and Liao, Wangjun and Shen, Zheyu and Rong, Xiaoxiang},
title = {Nanoparticle‐Based MRI‐Guided Tumor Microenvironment Heating via the Synergistic Effect of Ferroptosis and Inhibition of TGF‐ β Signaling},
journal = {Advanced Healthcare Materials},
year = {2023},
volume = {12},
number = {21},
doi = {10.1002/adhm.202300176}
}
EUVIMED